Weave is exhibiting at AMWA 2026, taking place November 4–7 in Washington, DC. Join us to explore how AI is supporting medical writing and regulatory content development across the drug development lifecycle.

Visit the Weave booth to see how organizations are streamlining document development with structured authoring, source-aware content, content reuse, and collaborative review workflows. Built for life sciences, Weave helps teams create high-quality, connected content while keeping medical writers and subject matter experts at the center of the process.

Whether you’re looking to improve drafting efficiency, simplify review cycles, or better connect content across programs, stop by the Weave booth for a live demonstration and to meet our team.

Book a meeting

Book a meeting

Join Weave at Booth 4815 at HLTH 2026 in Las Vegas on November 15-18, 2026. See how human-guided AI can help healthcare and life sciences teams streamline documentation, strengthen traceability, and improve collaboration across regulated, fast-moving workflows.

Book a meeting

Join Weave at Booth 205 at the ISPE AI in Life Sciences Summit 2026 . Learn how our human-driven approach to AI helps teams create, manage, and maintain documentation across the product lifecycle while improving traceability, consistency, and collaboration.

Two conversations. Two different vantage points on agentic AI in drug development.

Ari Caroline, Weave’s Co-founder and Chief Strategy Officer, will be at the AI Agent Conference on May 5, contributing to both.

2:05 PM
Agentic AI in Drug Development: From Discovery to Approval
Ari joins Saira Mueller (Morning Brew) and Umut Eser (Johnson & Johnson) to explore how agentic systems are showing up across the lifecycle—from early discovery through approval.

2:25 PM
Getting it Right: Applying Novel Agentic AI Capabilities in a High-Stake, High-Complexity Drug Development Setting
Ari will host a panel with Andrew Robertson (Takeda), Vada Perkins (Boehringer Ingelheim), and Viral Vyas (Bristol Myers Squibb), focused on what it actually takes to apply these systems in real, high-stakes environments.

From big-picture potential to practical application—both conversations stay grounded in what teams are working through right now.

---

Book a meeting

Weave at DIA Global Annual Meeting — Booth 1218

Don’t miss our talks:

Session Title:
The connected submission: How AI, automation, and intelligence are changing the regulatory ecosystem

Monday, June 15 | 1:05 – 1:35 PM | Innovation Theater 1

Session Description:
Regulatory teams are being asked to move faster while maintaining consistency and quality across increasingly complex submissions. Disconnected authoring processes and inconsistent standards make this difficult to scale.

Learn how AI-enabled authoring, process standardization, and automation can help teams accelerate submissions, improve consistency, and unlock new opportunities for regulatory intelligence and planning.

We’ll also share practical frameworks for implementing these capabilities within existing processes—what to change, what to keep, and how to approach adoption across teams.

Speakers:
Brandon Rice, CEO and Co-founder, Weave Bio
Katie Connelly, SVP, Global Head of Regulatory Affairs, Parexel

Tuesday, June 16 | 9:15 – 9:45 AM | Innovation Theater 3

Session Title:
Threading AI Throughout the Drug Development Lifecycle: An Enterprise Lens

Session Description:
Enterprise pharma teams face increasing pressure to move faster while maintaining the quality and consistency required for complex health authority interactions. Fragmented workflows and evolving data make this especially challenging at scale.

Learn how a unified, human-driven AI approach can help teams develop narratives more efficiently and consistently across the product lifecycle. We’ll share real-world lessons on selecting, implementing, and integrating AI within existing workflows.

Speakers:
Brandon Rice, CEO and Co-founder, Weave Bio
Andrew S. Robertson, Ph.D., JD, Vice President and Head of Global Regulatory Policy & Innovation, Takeda

Weave at Festival of Biologics USA — Booth 207

Weave is exhibiting at Festival of Biologics USA at Booth 207, where we’ll be showcasing how human-driven AI supports complex, document-intensive work across drug development. Stop by to see how AI helps organize and connect source information, assist with drafting and revision, and provide clear visibility into how documents evolve—while keeping experts in control.

Don’t miss our talk on Thursday, March 5 | 11:40 AM:

Human-Driven AI for Documentation in Drug Development

Drug development teams work with complex documentation across research, development, and clinical programs. This work is often high-stakes, commonly supports regulatory progression, and always requires accuracy, consistency, and clear accountability as complexity grows.

In this session, we’ll explore how human-driven AI can be applied to support sensitive, document-centric work without removing people from the process. Using Weave’s platform as a reference point, we’ll discuss how AI can help organize and connect source information, assist with drafting and revision, and provide better visibility into how documents evolve over time.

Rather than positioning AI as a replacement for expertise, this talk focuses on how machine learning can be used to support expert judgment, even in high-consequence contexts. Attendees will gain perspective on where AI can realistically add value, how to maintain appropriate human oversight, and what it takes to apply AI responsibly to document-intensive workflows in drug development.

Speaker: Brandon Rice, CEO

Weave at the Chief Medical Officers Summit 2026

Weave is excited to be part of the largest gathering of biotech Chief Medical Officers across indications, modalities, company stages, professional experience levels and geographic locations. This is the conference to connect with peers and develop the skills needed to succeed as a biotech CMO.

Check back soon for more information on our talk!

Weave at Precision World Medicine Conference 2026

Weave’s Co-founder and CSO, Ari Caroline, will be part of the “Can AI Really Create the Next Blockbuster Drug? Closing the Loop from Discovery to Development” panel discussion on March 6, 2026 from 1:30 – 2PM in the AI Drug Discovery track.

Weave at SCOPE 2026 — Booth 525

Weave is excited to exhibit at SCOPE 2026 at Booth 525, where we’ll be showcasing how AI and automation support more efficient, human-driven regulatory workflows across clinical development. Stop by to meet the team and see how Weave reduces manual effort and improves consistency across regulatory document creation.

Don’t miss our talk on Wednesday, February 4 | 11:15 AM :

Clinical submissions by the numbers: quantifying the workflow impact of AI

Regulatory teams often operate with lean resources while facing increasing pressure to move quickly into early-stage clinical development. This session will highlight how Weave’s AI-native, human-driven platform uses automation to significantly reduce the manual burden of creating clinical-ready regulatory documents. By structuring information, auto-generating content, and providing real-time workflow visibility, Weave helps teams accelerate document development with greater consistency and fewer repetitive tasks. The session will also incorporate insights from Weave’s work with Parexel, illustrating how AI-enabled automation can streamline real-world regulatory workflows. Attendees will gain practical strategies for applying AI and automation to speed document preparation while allowing teams to stay focused on scientific and clinical decision-making.roving workflow visibility.

Speaker: Brandon Rice, CEO

Weave at DIA RSIDM 2026 – Booth #100

Weave is proud to be a sponsor at DIA Regulatory Submissions, Information, and Document Management (RSIDM) Forum 2026, taking place February 2-4, 2026 in Bethesda, Maryland. Visit us at our booth to connect with the team and see how Weave supports more fluid, human-driven regulatory workflows for development teams across the industry.

Don’t miss our talk: February 3, 2026 10:05 – 10:35 AM

Human + AI — Weave + Parexel: Revolutionary Collaborations in 2026

Regulatory teams face increasing pressure to deliver high-quality, submission-ready documents on tight timelines, yet many processes still rely on manual, repetitive steps that slow progress and introduce inconsistencies. Brandon’s session will explore how Weave’s AI-native, human-driven platform applies automation to streamline key aspects of regulatory document development—from structuring source information to auto-generating content and improving workflow visibility.

Drawing on Weave’s work with Parexel, this case study will illustrate how automation can support real-world regulatory workflows, reduce manual effort, and improve consistency across documents. Attendees will gain practical guidance on modern, AI-enabled approaches that help teams work more efficiently and achieve more predictable timeline outcomes while maintaining the centrality of human expertise.

Featured Topics Include:
• Applying AI and automation to reduce manual effort in regulatory document development
• Using structured information and auto-generated content to improve consistency and accuracy
• Enhancing workflow visibility and predictability for IND, CTA, and other key submissions
• Real-world learnings from Weave’s collaboration with Parexel
• Practical strategies for integrating human-driven AI into regulatory operations

Presenter: Brandon Rice, CEO